Clarity’s IP Strategy

Clarity’s patent strategy is based on filing new patent applications, supporting already granted patents in major markets as well as extending existing patents with divisional applications and patent continuations to capture and protect all the inventions underlying Clarity’s pipeline.

Originating from pioneering work at the Australian National University, the University of Melbourne and Australian Nuclear Science and Technology Organisation, Clarity has expanded its patent base, protecting its proprietary SAR Technology platform, existing products, Discovery Program pipeline, manufacturing and processes.

Clarity’s current patent portfolio covers a broad range of countries and major markets, including but not limited to United States, Australia, Europe, Japan, China, Canada, Singapore, Malaysia, South Korea, Russia, Mexico and India.

Patent Approach

The Platform Protection is covered by granted patents and new patent applications over a broad family of novel SAR (sarcophagine) chelators and linkers. The multiple patent families enforce both offensive and defensive strategies that support the chelators used in lead products.

The Product Protection is covered by granted and new patent applications that include composition of matter patents on the lead compounds.

The Pipeline Protection is covered by existing and new patent applications that protect the chelators, linker chemistry, targeting moiety or the whole compound that is being developed and uses thereof.

Manufacturing and Process Protection is covered by new applications that may include formulation, radiolabelling, stability and/or synthesis methods.